STAFF at Mount Vernon cancer centre are researching the effects of a blood thinning agent on lung cancer patients.
Doctors believe Dalteparin may increase the quality of life for lung cancer sufferers and stop them getting blood clots.
Dr Janette Dickson, a researcher at the centre said: "We are working hard to find better and more effective ways to treat this difficult illness."
Comments: Our rules
We want our comments to be a lively and valuable part of our community - a place where readers can debate and engage with the most important local issues. The ability to comment on our stories is a privilege, not a right, however, and that privilege may be withdrawn if it is abused or misused.
Please report any comments that break our rules.
Read the rules hereComments are closed on this article